Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Apex Healthcare Bhd's Cyclically Adjusted PB Ratio or its related term are showing as below:
XKLS:7090'
s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.51 Med: 3.73 Max: 5.77
Current: 3.1
During the past years, Apex Healthcare Bhd's highest Cyclically Adjusted PB Ratio was 5.77. The lowest was 2.51. And the median was 3.73.
XKLS:7090's Cyclically Adjusted PB Ratio is not ranked
in the Medical Distribution industry.
Industry Median: 1.135
vs XKLS:7090: 3.10
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Apex Healthcare Bhd's adjusted book value per share data for the three months ended in Sep. 2025 was RM1.080. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is RM0.84 for the trailing ten years ended in Sep. 2025.
Shiller PE for Stocks: The True Measure of Stock Valuation
Apex Healthcare Bhd (XKLS:7090) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Apex Healthcare Bhd Cyclically Adjusted PB Ratio Related Terms
Apex Healthcare Bhd Cyclically Adjusted PB Ratio Historical Data
* Premium members only.
The historical data trend for Apex Healthcare Bhd's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apex Healthcare Bhd Cyclically Adjusted PB Ratio Chart
XKLS:7090 vs MCK, COR, CAH: Cyclically Adjusted PB Ratio Comparison
For the Medical Distribution subindustry, Apex Healthcare Bhd's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Healthcare Bhd Cyclically Adjusted PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Apex Healthcare Bhd's Cyclically Adjusted PB Ratio falls into.
Apex Healthcare Bhd Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Apex Healthcare Bhd's Cyclically Adjusted PB Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 3.11 mean?
Apex Healthcare Bhd (XKLS:7090) has a Cyclically Adjusted PB Ratio of 3.11 as of Jul. 29, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Apex Healthcare Bhd and its competitors. This is 17% below median its historical median of 3.73. Over the past decade, Apex Healthcare Bhd's Cyclically Adjusted PB Ratio has ranged from 2.51 to 5.77.
Is Apex Healthcare Bhd's Cyclically Adjusted PB Ratio too high?
Apex Healthcare Bhd's current Cyclically Adjusted PB Ratio of 3.11 is 17% below median its 10-year median of 3.73. Over the past 10 years, this metric has ranged from a low of 2.51 to a high of 5.77. The Medical Distribution industry median Cyclically Adjusted PB Ratio is 1.14. Apex Healthcare Bhd's value of 3.11 is 174% above this industry median. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's Cyclically Adjusted PB Ratio compare to MCK and COR?
Apex Healthcare Bhd's Cyclically Adjusted PB Ratio of 3.11 can be compared against companies in the Medical Distribution industry. The industry median Cyclically Adjusted PB Ratio is 1.14. Apex Healthcare Bhd's value of 3.11 is 174% above this benchmark. Historically, Apex Healthcare Bhd's own Cyclically Adjusted PB Ratio has ranged from 2.51 to 5.77 over the past decade. While the company's 10-year median is 3.73 vs. the industry median of 1.14, Apex Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Medical Distribution company?
The median Cyclically Adjusted PB Ratio among Medical Distribution companies is 1.14, based on 92 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apex Healthcare Bhd's current Cyclically Adjusted PB Ratio of 3.11 is 174% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Apex Healthcare Bhd and its competitors. For the Medical Distribution industry, the median Cyclically Adjusted PB Ratio is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current Cyclically Adjusted PB Ratio is 3.11, which is 17% below median its own 10-year median of 3.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current Cyclically Adjusted PB Ratio of 3.11. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current Cyclically Adjusted PB Ratio is 3.11, which is 17% below median its 10-year median of 3.73 and 174% above the Medical Distribution industry median of 1.14. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current Cyclically Adjusted PB Ratio is 3.11 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued.
The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.
Key valuation signals for XKLS:7090:
Cyclically Adjusted PB Ratio: 3.11 (17% below median its 10-year median of 3.73)
GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
Industry Position: 174% above the Medical Distribution median
No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score
Get the complete analysis for XKLS:7090
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7090 has been successfully added to your 
